CD19 and lung carcinoma: The frequency of peripheral Bregs (CD19+CD24hiCD27+) and CD19+IL-10+B cells in CD19+B cells in lung cancer patients were significantly higher than in the healthy, as shown on Figure 1E and F (P <0.001 and 0.05, respectively).